Results
22
Mid-Large Cap Stocks
22 companies
Seegene
Market Cap: ₩1.4t
Manufactures and sells molecular diagnostics products worldwide.
A096530
₩31,200.00
7D
17.7%
1Y
40.2%
ST PharmLtd
Market Cap: ₩1.5t
Provides custom manufacturing services for active pharmaceutical ingredient and intermediates in South Korea and internationally.
A237690
₩74,600.00
7D
-1.2%
1Y
-22.4%
Caregen
Market Cap: ₩1.7t
A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.
A214370
₩34,300.00
7D
46.6%
1Y
55.9%
GC Biopharma
Market Cap: ₩1.4t
A biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally.
A006280
₩124,300.00
7D
4.4%
1Y
8.5%
SK bioscienceLtd
Market Cap: ₩3.2t
Engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally.
A302440
₩40,300.00
7D
0.2%
1Y
-32.9%
Peptron
Market Cap: ₩4.4t
Engages in the development of peptide-based medicines.
A087010
₩188,200.00
7D
8.8%
1Y
513.0%
PharmaResearch
Market Cap: ₩4.3t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩410,000.00
7D
4.2%
1Y
198.6%
Hanmi Pharm
Market Cap: ₩3.7t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩292,000.00
7D
12.3%
1Y
-9.3%
NatureCellLtd
Market Cap: ₩1.6t
Engages in manufacturing and selling of canned and health functional food products, beverages, stem cell, and cosmetics in South Korea.
A007390
₩24,200.00
7D
-7.1%
1Y
145.2%
ABL Bio
Market Cap: ₩3.0t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩61,500.00
7D
-1.3%
1Y
150.0%
SK Biopharmaceuticals
Market Cap: ₩7.1t
A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.
A326030
₩90,700.00
7D
-7.4%
1Y
1.2%
ALTEOGEN
Market Cap: ₩17.6t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩331,000.00
7D
-6.1%
1Y
86.0%
Hugel
Market Cap: ₩3.8t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩350,000.00
7D
-4.8%
1Y
76.8%
Celltrion Pharm
Market Cap: ₩2.0t
A pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea.
A068760
₩47,050.00
7D
-1.8%
1Y
-49.9%
Kolon TissueGene
Market Cap: ₩2.8t
Develops cell therapies to target various orthopedic diseases and degenerative disorders.
A950160
₩34,200.00
7D
-8.7%
1Y
173.2%
Sam Chun Dang Pharm
Market Cap: ₩3.5t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩151,000.00
7D
7.2%
1Y
36.0%
Celltrion
Market Cap: ₩32.7t
Develops and produces drugs based on proteins for the treatment of oncology in South Korea.
A068270
₩153,500.00
7D
-3.7%
1Y
-16.5%
Samsung BiologicsLtd
Market Cap: ₩71.0t
Together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩998,000.00
7D
-3.7%
1Y
27.3%
LigaChem Biosciences
Market Cap: ₩3.7t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩102,300.00
7D
1.8%
1Y
52.5%
Yuhan
Market Cap: ₩8.0t
Manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally.
A000100
₩107,000.00
7D
-2.6%
1Y
44.6%
Voronoi
Market Cap: ₩1.9t
Researches, develops, and discovers small molecule kinase inhibitors in South Korea.
A310210
₩105,000.00
7D
10.5%
1Y
215.8%
Daewoong Pharmaceutical
Market Cap: ₩1.6t
Manufactures and sells pharmaceutical products in South Korea and internationally.
A069620
₩142,900.00
7D
0.1%
1Y
28.3%